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SUMMARY -Characterization of hematomas is essential in scan reading, manual delineation, and designing automatic segmentation algorithms. Our purpose is to characterize the distribution of intraventricular (IVH) and intracerebral hematomas (ICH) in NCCT scans, study their relationship to gray matter (GM), and to introduce a new tool for quantitative hematoma delineation. We used 289 serial retrospective scans of 51 patients. Hematomas were manually delineated in a two-stage process. Hematoma contours generated in the first stage were quantified and enhanced in the second stage. Delineation was based on new quantitative rules and hematoma profiling, and assisted by a dedicated tool superimposing quantitative information on scans with 3D hematoma display. The tool provides: density maps (40-85HU), contrast maps (8/15HU), mean horizontal/ vertical contrasts for hematoma contours, and hematoma contours below a specified mean contrast (8HU)
) whereas the GM-GS correlation is weak (R 2 =0.14; p<10 -10 ). The 
Introduction
Characterization of the density distribution of hematomas is essential in scan reading, manual delineation, and designing automatic segmentation algorithms. Intraventricular hemorrhage (IVH) or bleeding into the ventricular system often results from severe intracerebral hemorrhage (ICH); this complication has a mortality rate of 60-80% and only about 10% of patients recover with a good outcome 1 . The Phase II trials promise better outcomes associated with catheter-based drug delivery and pharmacologic clot reduction. Objective, quantitative volume measurement has been essential to characterize drug action and treatment goals 1, 3 . This treatment requires multiple non-contrast computed tomography (NCCT) scans to be acquired to monitor clot lysis. For each scan, a hematoma (IVH jointly with ICH) is delineated, its volume measured, and treatment progression assessed. Standardizing these objective measurements for clinical practice is critical for clinically useful treatment assessment.
The CLEAR and MISTIE trials use NCCT for hemorrhage evaluation, as this modality is fast, provides generally high contrast between tissue and blood, and is available in most hospitals and emergency departments. On NCCT brain scans, blood appears hyperdense, soft tissues isodense, and cerebrospinal fluid (CSF) hypodense. Some sources provide absolute ranges in Hounsfield units (HU) of blood, clotted blood and its fractions [4] [5] [6] [7] [8] [9] [10] . However, definition and delineation of hematomas on NCCT is not straightforward because of their variations in shape, size, location, density (intensity), contrast and texture. Moreover, imaging factors, such as partial volume effect (volume averaging), fuzzy and low contrast borders, noise, beam hardening, motion artifacts, and head tilt can further complicate the delineation of hematomas.
The purpose of this work is to characterize the density distribution of intraventricular and intracerebral hematomas in hemorrhagic stroke NCCT scans in terms of mean, median, standard deviation, maximum, full width at half maximum, skewness and kurtosis, both overall and per day. We also study the relationship between the density distributions of gray matter (GM) and hematoma. In addition, we formulate rules defining IVH and ICH on NCCT, propose a two-stage process for quantitative hematoma delineation, and introduce a new tool aiding quantitative hematoma delineation.
Materials and Methods

Materials
Scan selection. This study was IRB-approved and HIPAA compliant. A cohort of 317 NCCT serial anonymized scans (acquired predominantly on a daily basis) of 53 IVH/ICH patients was selected from CLEAR IVH, CLEAR III and MISTIE II clinical trials. The patients were chosen to be representative of hemorrhages within different study cohorts, including IVH only, ICH only, both IVH and ICH, and ICH at originating in different locations. From this cohort, we excluded scans with 1) severe artifacts, such as beam hardening, to avoid distortion of white matter (WM), GM and hematoma density characteristics; 2) air within the hematoma to avoid distortion of hematoma characteristics (unless the air-occupying regions could be eliminated from hematoma); 3) cleared clots as their characteristics could not be determined; and 4) hematomas in subarachnoid spaces; 289 scans of 51 patients were included in this study.
Patient/scan description. Patients' mean age and standard deviation (SD) were 56.8±11.5 yrs; 55% of them were male and 45% female. Their scans were acquired between 2004.01.11-2012.04.14 and divided into eight groups for day 1, day 2, …, and day 8 and later. The scans were performed on GE, Philips, Siemens and Toshiba CT devices, and the X-Ray tube potential ranged between 120 and 140kV. The scan number per day was the following: one, 74(25.6%); two, 39(13.5%); three, 32(11.1%); four, 32(11.1%); five, 27(9.3%); six, 21(7.3%); seven, 14(4.8%); and eight+, 50(17.3%). The slice thickness varied between 2.10 and 7.48 mm with mean±SD 4.55±0.79 mm and the matrix was 512×512.
Methods
Hematoma delineation. IVH/ICH hematomas for all scans were delineated retrospectively (by WLN) in two stages, qualitative and quantitative (see also Appendix B for illustration). In the first qualitative stage, the hematoma region was considered a hyperdense area with HU approximately between 40 and 85. Isodense regions following the borders of the ventricular system (particularly in the posterior horns of the lateral ventricles with clear gravitational fluid leveling) were included in the delineated hematoma region. The exclusion areas corresponded to the catheter, bone, calcifications, and dura matter. To delineate hematomas on acquisition (axial) images interactively, we used the contour editor employed earlier to delineate ischemic infarcts 11 . For the hematomas delineated in the first stage, regions outside the 0-100HU range were excluded as 1 st /99 th percentiles of the aggregated hematomas were 30/82HU (also confirmed by the literature, Section 4). We considered contrast between the hematoma and the surrounding structures by providing the mean contrast for each hematoma contour, and contrast maps for all scans. Contrast was calculated along horizontal and vertical lines of each slice. For a given pixel, its horizontal (vertical) contrast was computed as an absolute difference of the mean of HU of the consecutive n pixels to the left (top) and the mean of HU of
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The overall (across all scans) hematoma mean contrast was calculated in two ways, as the average of hematoma contour mean contrasts or average of boundary pixel contrasts. The averages of hematoma contour mean contrasts were 15.4/12.7HU for the horizontal/vertical contrasts. The averages of hematoma boundary pixel contrasts were 16.1HU/12.5HU/16.6HU for the horizontal/vertical/higher of either contrast. Moreover, the contrast map of 15HU corresponded well visually to the hematoma boundaries. Therefore for further analysis, we took 15HU or higher as the hematoma-surrounding structures contrast.
In the second quantitative stage, the he- matoma regions were enhanced quantitatively by considering their HU density, hematoma contrast and three-dimensional (3D) relationships. The contour editor was extended to calculate: 1) density maps for a specified range (taken here as 40-85HU) indicated by differently colored pixels within and outside this range (see Appendix B, Figure 8 ); 2) contrast maps for a given contrast (taken here as 15HU or higher), 3) mean horizontal and vertical contrasts for all hematoma contours; and 4) to determine all hematoma contours below a specified mean contrast (taken here as 8HU). Moreover, the contour editor reconstructs the hematoma in 3D and provides 3D-2D spatial synchronization for visual comparison (see Appendix B, Figure 9 ). Using this editor and extending the set of rules defining hematoma (see Appendix A), the hematoma regions delineated in the first stage were re-edited as follows. The areas of 0HU and 100HU were eliminated from analyzed regions. The density map for each scan was superimposed on it, and under-segmented and/or over-segmented hematoma contour boundaries were fit accordingly to this map (see Appendix B, Figure 8F ). As the ranges of WM and GM were quite variable across all cases, there were situations (particularly for low means of WM and GM) in which clearly discernible hematomas were below 40HU. Then, the contrast map was applied to fit the re-edited hematoma boundary to the contrast of 15HU or higher (see Appendix B, Figures 7 and 8E ). In three situations (regions), this contrast was still too high. First, isodense areas, that are within the ventricles (particularly when they form clear gravitational fluid leveling) or are located in the aqueduct, indicate hematoma. These areas usually have low signal and contrast, and fuzzy borders, particularly in the posterior horns of the lateral ventricles. For such regions, the density map was not applied and the contrast was reduced to 8HU. A processed hematoma contour was re-edited to fit its boundary to this contrast map and, if its mean contrast was 8HU or higher, this contour was retained; otherwise it was deleted (considered a partial volume effect region). Second, some isodense or slightly hyperdense areas within the parenchyma are questionable, as they could result from: 1) dorsal and/or ventral extension of hematoma, 2) partial volume effect, or 3) a mixture of both. Similar processing was applied in this case. Third, some hyperdense ICH close to the skull have unclear internal boundaries. In these cases, the density map typically indicates a false connection to the skull, the contrast map of 15HU does not show a boundary, whereas the contrast of 8HU does.
The contrast width n was generally taken as 5. When the mean hematoma contrast of 8HU could not be obtained for n=5, this value was varied. For fuzzy hematomas, their contrast width was extended to 7. For very small (e.g., aqueductal) clots and narrow elongated clots, the contrast width was reduced to 3 to avoid inclusion of non-hematoma pixels in the calculation of hematoma-dependent contrast. Proximity of a catheter, calcification and/or air may distort the actual contrast value. Therefore, any hematoma boundary pixel, having in its contrast width pixel(s) in the range of 0HU or 100HU was excluded from contrast calculation. A 3D surface modeled hematoma was displayed to evaluate its connectedness, shape inconsistency and/or artifacts. Every 3D component of the hematoma was mapped to the corresponding 2D contour(s). Neighboring 3D components, if required, were connected by extending their corresponding contours (particularly in the aqueduct, see Figure 9 in Appendix B). In shape inconsistency, the contours in neighboring slices were re-evaluated. In case of gaps between the neighboring and overlapping contours in the dorso-ventral direction (easily identifiable in 3D), the missing contours were created such as to meet the hematoma criteria.
Characterization of hematoma, WM and GM. Overall and per day hematoma mean, median, SD, maximum, Full Width at Half Maximum (FWHM), skewness, kurtosis, and percentiles were calculated. In addition, overall and per day WM and GM mean, median, and SD were computed automatically for each scan applying the algorithm 13 . We also studied: 1) correlation between WM and GM distributions; 2) correlation between GM and hematoma distributions; and 3) hematoma contrast distribution.
Statistical analysis
The MATLAB ® /7.8.0.347 software tool 13 was used for statistical analysis. Means, medians, SDs, skewness, kurtosis and percentiles were calculated to characterize hematoma distribution. WM, GM and hematoma means were tested by one-way ANOVA test to detect significant differences. Least Significance Difference test was used to confirm the significance between means of WM-GM, WM-hematoma and GM-hematoma, and differences between hematoma means at respective days. The differences were considered significant if p<0.05 after Bonferroni's correction. Pearson's linear and Spearman's range correlation coefficients were calculated between means of WM-GM and GM-hematoma.
Results
The IVH/ICH definition criteria were formulated (summarized in Appendix A) and 8, 205 hematoma contours set on all 289 scans. The contour editor has been extended to provide the density and contrast maps, see Appendix B (Figures 7-10) . Tables 1-3 present the characteristics of WM, GM and hematoma (over- all and per day). Means, medians and SDs of WM, GM and hematoma are in Table 1 . Table 2 provides hematoma percentiles and Table 3 hematoma maximum, FWHM, skewness and kurtosis. Figure 1 shows HU distributions of WM, GM and hematoma. Figure 2 presents overall and per day hematoma distributions. Figure 3 illustrates the relationships between GM and hematoma distributions, while Table 4 lists HU values with GM and hematoma percentiles in the neighborhood of the GM-hematoma distribution intersection. Figures 4 and 5 present scatter plots of WM-GM and GM-hematoma. Figure 6 shows hematoma contrast distribution plots. ANOVA test revealed significant differences between the WM, GM and hematoma means [F=3574.48, p<0.0001]. Least significant difference test showed the means of WM-GM, WM-hematoma and GM-hematoma are significantly different (p<10 -10 ). There were no significant differences between hematoma means at days 1-4 (p>0.05). The means±SDs of horizontal/vertical/higher of both contrasts were: 17.0 ± 10.7/13.3 ± 9.7/20.8 ± 9.9, 19.7 ± 11.6/15.9 ± 10.9/23.9 ± 10.6, and 20.9 ± 12.1/17.4 ± 11.5/25.5 ± 10.8 for the contrast width 3, 5 and 7.
Discussion
Hematoma, WM and GM characterization.
This study advances our knowledge in quantitative characterization of hematoma on NCCT, and its relationship to WM and GM. IVH/ICH hematoma on serial NCCT, whose delineation was assisted by applying the density and contrast maps and 3D-2D spatial correlation, is characterized by 59.0HU mean, 60.0HU median, 11.6HU standard deviation, 23.9HU mean contrast and -0.99HU/day slope (i.e., the density decrement per day). The overall hematoma distribution gains its maximum at 67.2HU with 31.3HU FWHM, 2.44 kurtosis and -0.24 skewness (which changes in time from negative to positive, Figure 2a) . The hematoma 0.1 st -99.9 th percentile range corresponds to the 25-88HU range. Low density hematoma areas resulted mostly from CSF embedded into hematoma and the hematoma-CSF partial volume effect, whereas areas with 0HU from air penetrating the brain due to an inserted catheter. Areas with 85HU resulted mainly from the partial volume effect in the regions when hematoma neighbored a catheter, bone, or calcifications.
Other studies report flowing blood of 51HU ; and hemorrhage 50-70HU 6, 7 , 40-60HU immediate and 60-80HU over one hour (or described as an acute) 6, 16 , 50-80HU percentiles. The effect of decreased hematoma density with hematoma aging is known 6, 19 . Here it was measured and quantified. The overall means±SDs of WM and GM are 28.3±5.2HU and 37.3±6.1HU, and their ratio is 0.76±0.02. These results (i.e., calculated automatically by applying the algorithm ; and WM/GM ratio for normal brain of 0.76±0.14 23 . WM and GM are highly correlated (R 2 =0.88) whereas the GM-hematoma correlation is weak (R 2 =0.14) (both are significant, p<10 -10 ). The hematoma distribution substantially overlaps with that of GM ( Figure 3 , Table 4 ). The mean GM-hematoma intersection point is at 55.6±5.8HU with the corresponding GM/ hematoma percentiles of 88 th /40 th . This clearly indicates that manual hematoma segmentation is difficult and automatic density-based segmentation impossible.
Implications for patient care. The hematoma boundary is set here based on new rules, hematoma profiling, and employing a dedicated Table 4 HU values with corresponding GM and hematoma percentiles in the neighborhood of intersection of the overall GM and hematoma distributions.
tool developed in-house. Stating these (inclusion, exclusion and enhancement) rules explicitly and quantitatively will aid different raters to delineate hematomas more robustly and facilitate designing algorithms for automatic hematoma segmentation. This is particularly important taking into account a substantial overlap in density between hematoma and GM. The hematoma delineation process is made quantitative by providing the human observer with the density and contrast maps between the hematoma and surrounding structures superposed on a scan along with synchronization of a 3D hematoma model with a scan.
We have proposed a two-stage process for hematoma delineation. Having the first stage hematoma contours allows them in the second stage to be quantified, displayed in 3D, and superimposed on the density and contrast maps for further enhancement.
The more accurate segmentation of hematoma results in its both more accurate volume and shape. It is well known that hematoma volume is essential for prognosis 24 .
To estimate hematoma volume, the so-called ABC/2 method is often employed (also in the CLEAR and MISTIE clinical trials) based on the measurements of the three maximal diameters of the hematoma 25 (i.e., without marking its borders). This method, though rapid, leads to substantial error 26, 27 . The accurately delineated series of hematomas result in more accurate volumes, facilitate making quantitative decisions (e.g., stopping the treatment when the hematoma volume is reduced by 80%), and enable checking for potential rebleeding by comparing the shapes and sizes of consecutive hematomas in 3D.
Though traditionally CT was considered the modality of choice for hemorrhagic stroke diagnosis, MRI has been demonstrated to be as accurate as CT 28 and this work can be extended to support delineation of hematomas on MRI. Moreover, although this work focuses on IVH/ ICH on NCCT, the computer-assisted approach proposed here to delineate hematomas is general and potentially applicable to delineate other pathologies on various modalities more robustly and quantitatively. The 15HU contrast resulted from the quantitative contrast analysis between the hematoma and surrounding structures, and the contrast map of 15HU corresponded well to the hematoma boundaries. As the ventricular system has a larger antero-posterior than lateral extent, the mean horizontal contrast is higher, whereas there are more contour points with low vertical contrast ( Figure 6 ). Therefore, the higher of these two contrasts better characterizes the hematoma distribution. Note that all three contrast curves intersect at 15HU (Figure 6) .
The 8HU contrast was observed in true hematomas in posterior horns with clear leveling and a clotted aqueduct. We applied the same contrast threshold to separate a hematoma from partial volume effect regions. Note that the 8HU difference is also recommended in European Guidelines on Quality Criteria for Computed Tomography to test image uniformity and measure CT numbers 29 .
Limitations. The scans were acquired using multiple sites' CT scanners without an effort to standardize the HU across sites. Only routine clinical calibration procedures were employed by each site. Gender-, age-, and ethnicity-specific analyses were not performed in this study. The thresholds taken here (40/15/8HU) are absolute, although the hematoma characteristics vary across acquisitions and time. Potentially more accurate hematoma delineation could be achieved by expressing these thresholds as functions of WM or GM (Figures 4 and 5) . It is questionable how to include in or exclude from the delineated hematoma the regions having a mixture of pixels within and outside the specified density range. To handle this situation quantitatively requires the tool to be extended, e.g., to calculate the inside/outside ratio and include a considered region if this ratio is 0.5.
Future work. The results of this work are being used to enhance automatic segmentation of hematomas in NCCT in our previous algorithms. We are also in the process of analyzing the contrast of ischemic infarcts on NCCT from the study 11 . Further studies are planned to correlate the current results with hematoma volume (measured by the clinicians and automatically), and to analyze IVH and ICH separately. Editor with the Density and Contrast Maps Figure 7 shows an NCCT scan of a hematoma with fuzzy borders, the density map (between 40-85HU) superimposed onto the scan, and the contrast map (15HU or higher) superimposed onto the scan. Figure 8 illustrates the use of the density and contrast maps in the process of hematoma delineation. Figure 9 illustrates the 3D-2D relationships used to identify undersegmented regions of the hematoma. Figure 10 illustrates the definition of the vertical and horizontal contrasts. Figure 8 Illustration of the use of the density and contrast maps in the process of hematoma delineation. A) Original scan with the hematoma. B) Hematoma delineated in the first qualitative stage (the contour is set by manipulating the control points (marked in yellow on the contour marked in magenta). C) Density map (in green and red) superimposed on the contoured hematoma; the red pixels neighboring the hematoma border and lying inside the hematoma indicate the over-segmented regions, whereas the green pixels lying outside the hematoma indicate the under-segmented regions. D) Hematoma delineation enhanced by the density map (in the ideal case, the over-and under-segmented regions should be eliminated, which is indicated in the density map by the absence of the red and green pixels (circles) in the hematoma border); note: to increase the accuracy of editing, the image was highly magnified (in comparison to image C) resulting in smaller green circles outside the hematoma. E) Contrast map along with the delineated hematoma. F) Both contours (images C,D) magnified to highlight the differences between them (the red arrows point to the under-segmented regions and the green arrows to the over-segmented regions). Illustration of the 3D-2D relationships used here to identify under-segmented regions of the hematoma. The 3D hematoma (right) shows a missing connection (the aqueduct) between the third and the fourth ventricles, and the cross on the scan (left), whose location correspond to that in 3D, indicates its position (i.e., these two crosses are used for spatial 3D-2D synchronization).
